HBHelena S. Blumenau

Helena S. Blumenau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Helena S. Blumenau has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Strategies to establish a biologically defined Parkinson’s disease cohort prior to the onset of clinically significant motor symptoms

    by Ethan G. Brown, Helena Blumenau, David-Erick Lafontant, Anuprita R. Nair, Noah Johnson, Roy N. Alcalay, Lana M. Chahine, Christopher S. Coffey, Roseanne D. Dobkin, Tatiana Foroud, et al.

    Identifying individuals at risk for neurodegeneration is a priority for clinical trials. Parkinson’s Precision Medicine Initiative (PPMI) deploys strategies to enroll individuals before typical clinical Parkinson’s disease symptoms: recruiting polysomnogram-confirmed REM sleep behavior disorder (RBD) and central identification of hyposmia via smell testing. Groups were divided into RBD with and without hyposmia (RBD+Hyposmia, RBD-Hyposmia) and hyposmia with and without self-reported dream enactment behavior (Hyposmia+DEB, Hyposmia-DEB). Participants underwent clinical and biomarker testing including CSF alpha-synuclein seed amplification assay (CSFaSynSAA) and dopamine transporter imaging. While all enrollment strategies showed robust enrichment for CSFaSynSAA positivity, RBD+Hyposmia and Hyposmia+DEB were more likely CSFaSynSAA+ (94% and 85%) vs RBD-Hyposmia (40%) and Hyposmia-DEB (55%). Among CSFaSynSAA+, RBD+Hyposmia and Hyposmia+DEB had more mood, autonomic, and cognitive symptoms than Hyposmia-DEB. PPMI identified a large biologically-defined early neuronal synucleinopathy cohort and demonstrated biomarker and multi-domain clinical heterogeneity within CSFaSynSAA+ individuals prior to symptom onset.

  • Top Cited Papers

    Gender differences in attitudes toward bisexual people and bisexuality: A systematic review and meta-analysis.

    by Eric Julian Manalastas, Helena S. Blumenau, Brian A. Feinstein

    Previous meta-analyses have examined gender differences in people's attitudes toward lesbian/gay sexualities, finding that, overall, men hold more homonegative attitudes than women (Kite et al., 2021; Petersen & Hyde, 2011). Bisexuality scholars have suggested a similar gender difference in attitudes toward bisexuality (Dyar & Feinstein, 2018). This study is the first meta-analysis to provide a comprehensive quantitative synthesis of gender differences in attitudes toward bisexual people and bisexuality. We synthesized findings from 61 studies (including 10 unpublished papers) from 1999 to 2022 that reported on 77 samples of 32,010 participants (14,359 men and 17,651 women). Overall, men held more binegative attitudes than women, g = 0.19 (95% CI = 0.14, 0.25). This effect was moderated by target gender: men were more binegative than women when considering male bisexuality, g = 0.27 (95% CI = 0.20, 0.35); the effect was substantially smaller when considering female bisexuality, g = 0.10 (95% CI = 0.03, 0.16). In addition, heterosexual men were more binegative than heterosexual women, g = 0.26 (95% CI = 0.19, 0.33), while gay men's and lesbian women's attitudes toward bisexuality were similar, g = 0.04 (95% CI = -0.09, 0.16). Overall, these meta-analytic findings indicate that men, particularly heterosexual men, hold more binegative attitudes than women, especially toward male bisexuality. Given the pervasiveness of binegativity, interventions are needed to improve attitudes toward bisexuality, particularly men's attitudes toward bisexuality.